RE:RE:Rebranding the Sort1There is no magical solution. It's too late, given the financial situation of the company, to convince the stock market of the potential, unless they would come with five patients out of six with objectve responses after three or four months of treatment at the 200 mg dose next fall. The only realistic hope is a partnership on terms that are not too bad for Thera and that would provide the necessary cash.